Documentos de Machado T.M. | REDI

Regresar

Mostrando 3 resultados de: 3

Filtros aplicados

Área temáticas: "Medicina y salud"

Subtipo de publicación

Publisher

BMC Medicine(1)

The Lancet Infectious Diseases(1)

The Lancet Regional Health - Americas(1)

Área temáticas

Enfermedades(1)

Farmacología y terapéutica(1)

Fisiología humana(1)

Medicina forense; incidencia de enfermedades(1)

Problemas sociales y servicios a grupos(1)

Área de conocimiento

Epidemiología(2)

Inmunología(2)

Salud Pública(1)

Año de Publicación

Origen

Palabras Claves

EFFECTIVENESS(1)

Inactivated vaccine(1)

CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study

Abstract: Background: More doses of CoronaVac have been administered worldwide than any other COVID-19 vaccine

Palabras claves:

covid-19, Inactivated vaccine, pregnant women, SARS-COV-2, Vaccine effectiveness

Alves F.J.O., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Júnior J.B.S., Machado T.M., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Pinto Júnior E.P., Rodrigues L.C., Werneck G.L., Wong K.L.M.

Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study

Abstract: Background: COVID-19 vaccines have proven highly effective among individuals without a previous SARS

Palabras claves:

Andrews J.R., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., Croda J., Cummings D.A.T., de Araujo Oliveira V., Dean N.E., Dorion M., Hitchings M.D.T., Júnior J.B.S., Ko A.I., Lind M.L., Machado T.M., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Ranzani O.T., Werneck G.L.

Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study

Abstract: Background: Aging influences COVID-19 severity and response to vaccination, but previous vaccine eff

Palabras claves:

CoronaVac, covid-19, EFFECTIVENESS, Vaccine, Vaxzevria

Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Barros J.V., Flores-Ortiz R.J., Ichihara M.Y.T., Júnior J.B.S., Machado T.M., Mauricio L. Barreto, Oliveira V.D.A., Penna G.O., Pescarini J.M., Werneck G.L.